HPTN Publications

Wei L, Chen J, Rodolph M, Beauchamp G, M 0226 Sse B, Li R, Wang S, Ruan Y, Lai S, Zhang L, Zhou F, Rose SM, Perdue T, Shao Y, Jackson JB . HIV Incidence, Retention, and Changes of High-Risk Behaviors Among Rural Injection Drug Users in Guangxi, China. Subst Abus. 2006, 274: 53-61 PMID: 17347126
Welte A, McWalter TA, Laeyendecker O, Hallet TB . Using tests for recent infection to estimate incidence: Problems and Prospects for HIV. Euro Surveill. 2010, 15: pii: 19589 PMCID: 2937566
Wendel SK, Longosz AF, Eshleman SH, Blankson JN, Moore RD, Keruly JC, Quinn TC, Laeyendecker O . Short Communication: The Impact of Viral Suppression and Viral Breakthrough on Limited-Antigen Avidity Assay Results in Individuals with Clade B HIV Infection. AIDS Res Hum Retroviruses. 2017, 33: 325-327
Wendel SK, Mullis CE, Eshleman SH, Blankson JN, Moore RD, Keruly JC, Brookmeyer R, Quinn TC, Laeyendecker O . Effect of natural and ARV-induced viral suppression and viral breakthrough on anti-HIV antibody proportion and avidity in patients with HIV-1 subtype B infection. PLoS One. 2013, 8: e55525
Westheimer EF, Urassa W, Msamanga G, Baylin A, Wei R, Aboud S, Kaaya S, Fawzi WW . Acceptance of HIV Testing Among Pregnant Women in Dar-es-Salaam, Tanzania. J Acquir Immune Defic Syndr. 2004, 37: 1197-1205
Wheeler DP, Fields SD, Beauchamp G, Chen YQ, Emel LM, Hightow-Weidman L, Hucks-Ortiz C, Kuo I, Lucas J, Magnus M, Mayer KH, Nelson LE, Hendrix CW, Piwowar-Manning E, Shoptaw S, Watkins P, Watson CC, Wilton L . Pre-exposure prophylaxis initiation and adherence among Black men who have sex with men (MSM) in three US cities: results from the HPTN 073 study. J Int AIDS Soc. 2019, 22: e25223
Wheeler DP, Lucas J, Wilton L, Nelson LE, Hucks-Ortiz C, Watson CC, Hutchinson C, Mayer KH, Kuo I, Magnus M, Beauchamp G, Shoptaw S, Emel LM, Chen YQ, Hightow-Weidman L, Fields SD . Building effective multilevel HIV prevention partnerships with Black men who have sex with men: experience from HPTN 073, a pre-exposure prophylaxis study in three US cities. J Int AIDS Soc. 2018, 21 Suppl 7: e25180
Widdice LE, Hsieh YH, Silver B, Barnes M, Barnes P, Gaydos CA . Performance of the Atlas Genetics Rapid Test for Chlamydia trachomatis and Women's Attitudes Toward Point-Of-Care Testing. Sex Transm Inf. 2018, 45: 723-727
Williams C, Eisenberg M, Becher J, Davis-Vogel A, Fiore D, Metzger D . Racial disparities in HIV prevalence and risk behaviors among injection drug users and members of their risk networks. J Acquir Immune Defic Syndr. 2013, 63: S90-4
Williams JK, Wilton L, Magnus M, Wang L, Wang J, Dyer TP, Koblin BA, Hucks-Ortiz C, Fields SD, Shoptaw S, Stephenson R, O'Cleirigh C, Cummings V; HIV Prevention Trials Network 061 Study Team . Relation of Childhood Sexual Abuse, Intimate Partner Violence, and Depression to Risk Factors for HIV Among Black Men Who Have Sex With Men in 6 US Cities. Am J Public Health. 2015, 105: 2473-81
Wilson CM, Gray G, Read JS, Mwatha A, Lala S, Johnson S, Violari A, Sibiya PM, Fleming TR, Koonce A, Vermund SH, McIntyre J . Tolerance and Safety of Different Concentrations of Chlorhexidine for Peripartum Vaginal and Infant Washes: HIVNET 025. J Acquir Immune Defic Syndr. 2004, 35: 138-43
Wilson SE, Pedersen SL, Kunich JC, Wilkins VL, Mann DL, Mazzara GP, Tartaglia J, Celum CL, Sheppard HW . Cross-clade envelope glycoprotein 160-specific CD8+ cytotoxic T lymphocyte responses in early HIV type 1 clade B infection. AIDS Res Hum Retroviruses. 1998, 14: 925-37
Wind-Rotolo M, Durand C, Cranmer L, Reid A, Martinson N, Doherty M, Jilek BL, Kagaayi J, Kizza A, Pillay V, Laeyendecker O, Reynolds SJ, Eshleman SH, Lau B, Ray SC, Siliciano JD, Quinn TC, Siliciano RF . Identification of Nevirapine-Resistant HIV-1 in the Latent Reservoir after Single-Dose Nevirapine to Prevent Mother-to-Child Transmission of HIV-1. J Infect Dis. 2009, 199: 1301-9 PMCID:2703715
WM El-Sadr, D Donnell, G Beauchamp, HI Hall, LV Torian, B Zingman, G Lum, M Kharfen, R Elion, FM Gordin, V Elharrar, D Burns, A Zerbe, T Gamble, B Branson . Financial Incentives for Linkage to Care and Viral Suppression Among HIV-Positive Patients: A Randomized Clinical Trial (HPTN 065). JAMA Intern Med. 2017, 177: 1083-1092
Wong LH, Van Rooyen H, Modiba P, Richter L, Gray G, McIntyre JA, Schetter CD, Coates T . Test and Tell: Correlates and Consequences of Testing and Disclosure of HIV Status in South Africa (HPTN 043 Project Accept). JAIDS. 2009, 50: 215-22 PMCID:2729272
Woodsong C . Covert use of topical microbicides: implications for acceptability and use. Perspect Sex Reprod Health. 2004, 36: 127-31
Woodsong C, Alleman P, Musara P, Chandipwisa A, Chirenje M, Martinson F, Hoffman I . Preventive misconception as a motivation for participation and adherence in microbicide trials: evidence from female participants and male partners in Malawi and Zimbabwe. AIDS Behav. 2012, 16: 785-90 PMCID: 3658446
Woody G, VanEttne-Lee ML, McKirnan D, Donnell D, Seage G, Gross M . Substance Use Among Men who have Sex with Men: Comparison with a National Household Survey. J Acquir Immune Defic Syndr. 2001, 27: 86-90
Woody GE, Donnell D, Seage GR, Metzger D, Marmor M, Koblin BA, Buchbinder S, Gross M, Stone B, Judson FN . Non-injection substance use correlates with risky sex among men having sex with men: data from HIVNET. Drug Alcohol Depend. 1999, 53: 197-205
Young SD, Hlavka Z, Modiba P, Gray G, Rooyen HV, Richter L, Szekeres G, Coates T . HIV-Related stigma, social norms, and HIV testing in Soweto and Vulindlela, South Africa: National Institutes of Mental Health Project Accept (HPTN 043). J Acquir Immune Defic Syndr. 2010, 55: 620-4 PMCID: 3136617
Zhang Y, Clarke W, Marzinke MA, Piwowar-Manning E, Beauchamp G, Breaud A, Hendrix CW, Cloherty GA, Emel L, Rose S, Hightow-Weidman L, Siegel M, Shoptaw S, Fields SD, Wheeler D, Eshleman SH . Evaluation of a Multidrug Assay for Monitoring Adherence to a Regimen for HIV Pre-exposure Prophylaxis in a Clinical Study, HIV Prevention Trials Network 073.. Antimicrob Agents Chemother. 2017, 61
Zhang Y, Fogel JM, Guo X, Clarke W, Breaud A, Cummings V, Hamilton EL, Ogendo A, Kayange N, Panchia R, Dominguez K, Chen YQ, Sandfort T, Eshleman SH . Antiretroviral drug use and HIV drug resistance among MSM and transgender women in sub-Saharan Africa. AIDS. 2018, 32: 1301-1306
Zhang Y, Shan H, Trizzino J, Ruan Y, Beauchamp G, Mâsse B, Ma J, Gu Y, He Y, Rui B, Wang J, Poundstone K, Jiang Y, Brooks Jackson J, Shao Y . Demographic characteristics and risk behaviors associated with HIV positive injecting drug users in Xinjiang, China. J Infect. 2007, 54: 285-90 PMID: 16831464
Zhang Y, Shan H, Trizzino J, Ruan Y, Beauchamp G, Mâsse B, Ma J, Rui B, Wang J, Liu M, Wang Y, He Y, Poundstone K, Jiang Y, Jackson JB, Shao Y . HIV incidence, retention rate, and baseline predictors of HIV incidence and retention in a prospective cohort study of injection drug users in Xinjiang, China. Int J Infect Dis. 2007, 11: 318-23 PMID: 17321184
Zhang Y, Sivay MV, Hudelson SE, Clarke W, Breaud A, Wang J, Piwowar-Manning E, Agyei Y, Fogel JM, Hamilton EL, Selin A, MacPhail C, Kahn K, Gomez-Olive FX, Hughes JP, Pettifor A, Eshleman SH . Antiretroviral Drug Use and HIV Drug Resistance Among Young Women in Rural South Africa: HPTN 068. J Acquir Immune Defic Syndr. 2018, 79: 315-322
Zulu I, Schuman P, Musonda R, Chomba E, Mwinga K, Sinkala M, Chisembele M, Mwaba P, Kasonde D, Vermund SH . Priorities for Antiretroviral Therapy Research in Sub-Saharan Africa: A 2002 Consensus Conference in Zambia. J Acquir Immune Defic Syndr. 2004, 36: 831-34 PMCID: 2745050